Vestmark Advisory Solutions’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Vestmark Advisory Solutions's TVTX Position: Q3 2026 in Review
Vestmark Advisory Solutions opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 11,180 shares worth $658K. The stake represents 0.01% of the portfolio and ranks #1166 among its holdings.
345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Vestmark Advisory Solutions held 11,180 shares of Travere Therapeutics worth $658K as of Q3 2026.
- Travere Therapeutics was a new Vestmark Advisory Solutions position in Q3 2026.
- Travere Therapeutics made up 0.01% of Vestmark Advisory Solutions's portfolio in Q3 2026, its #1166 holding.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Vestmark Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.